Shares of Addus HomeCare Corporation (NASDAQ:ADUS) have received a consensus recommendation of “Hold” from the six ratings firms that are covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the company. The average 1 year price target among brokers that have covered the stock in the last year is $42.50.
A number of equities research analysts have recently weighed in on the stock. Zacks Investment Research downgraded shares of Addus HomeCare from a “buy” rating to a “hold” rating in a research note on Friday, August 18th. Oppenheimer restated a “buy” rating and issued a $45.00 price target on shares of Addus HomeCare in a research note on Tuesday, September 19th. Finally, Robert W. Baird restated a “hold” rating and issued a $40.00 price target on shares of Addus HomeCare in a research note on Thursday, August 24th.
Several institutional investors and hedge funds have recently bought and sold shares of the company. Sterling Capital Management LLC boosted its stake in shares of Addus HomeCare by 30.8% in the 3rd quarter. Sterling Capital Management LLC now owns 62,010 shares of the company’s stock valued at $2,189,000 after purchasing an additional 14,616 shares in the last quarter. Dimensional Fund Advisors LP boosted its position in Addus HomeCare by 2.3% during the 3rd quarter. Dimensional Fund Advisors LP now owns 887,121 shares of the company’s stock worth $31,316,000 after buying an additional 19,823 shares during the period. Jupiter Asset Management Ltd. boosted its position in Addus HomeCare by 2.7% during the 3rd quarter. Jupiter Asset Management Ltd. now owns 109,777 shares of the company’s stock worth $3,875,000 after buying an additional 2,872 shares during the period. Cadence Capital Management LLC boosted its position in Addus HomeCare by 5.0% during the 3rd quarter. Cadence Capital Management LLC now owns 35,707 shares of the company’s stock worth $1,260,000 after buying an additional 1,711 shares during the period. Finally, Oppenheimer & Co. Inc. boosted its position in Addus HomeCare by 25.8% during the 3rd quarter. Oppenheimer & Co. Inc. now owns 25,825 shares of the company’s stock worth $911,000 after buying an additional 5,289 shares during the period. Institutional investors own 92.97% of the company’s stock.
Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings data on Monday, November 6th. The company reported $0.42 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.38 by $0.04. Addus HomeCare had a net margin of 4.30% and a return on equity of 10.35%. The firm had revenue of $108.60 million for the quarter, compared to the consensus estimate of $108.99 million. During the same period in the prior year, the company posted $0.39 earnings per share. The business’s revenue for the quarter was up 4.9% on a year-over-year basis. research analysts forecast that Addus HomeCare will post 1.42 earnings per share for the current year.
About Addus HomeCare
Addus HomeCare Corporation is a provider of personal care services, which are provided primarily in the home. The Company’s personal care services include assistance with bathing, grooming, oral care, skincare, assistance with feeding and dressing, medication reminders, meal planning and preparation, housekeeping and transportation services and other activities of daily living.
Receive News & Ratings for Addus HomeCare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare Corporation and related companies with MarketBeat.com's FREE daily email newsletter.